source
- Bristol Myers Squibb partners with Hengrui Pharma in $15.2 billion, 13-asset dealBristol Myers Squibb announced a partnership with China’s Hengrui Pharma that includes 13 assets. The transaction is reported to be valued at up to $15.2 billion, highlighting the scale of collabo…
- Serif Biomedicines claims breakthrough in non-viral gene therapy demonstrated in monkeysSerif Biomedicines, a startup launched by Flagship Pioneering last month, announced it believes it has overcome two key technical hurdles that have limited non-viral gene therapy. The company says…